IMTX (Immatics Corp) Quick Liquidity

The current Immatics N.V. (IMTX) share price chart on the GURU.Markets platform reflects the dynamics of a company ensuring the flawless delivery of high-tech medicines through strict temperature control. The business relies on cooperation with global biotech giants to develop personalized methods for T-lymphocyte stimulation. The current indicator stands at 7.17, while progress in combating dense neoplasms creates a tangible impulse for price growth.

Immatics Biotechnologies (IMTX) - Critical Liquidity from 07/04/2022 to 10/29/2026

immatics.com (IMTX) - metric breakdowns and financial figures

- market value and analyst target forecast:

Price Chart Immatics Corp|IMTX - Price Target Chart

- business market valuation indicators:

Market Value Immatics Corp|IMTX - Total Enterprise Value

- book capitalization data:

Book Value per Share Immatics|IMTX - Book Value of Business|Market Cap to Net Assets Ratio immatics.com|IMTX - Company Assets

- company liabilities and liquidity data:

- earnings and valuation multiples indicators:

IMTX - Net Profit

Analysis of all company metrics:Immatics N.V.

For Immatics N.V. (IMTX), which is developing the high-tech XPRESIDENT platform for solid tumor therapy, access to immediate R&D resources is critical. This quick ratio is calculated as the ratio of cash and accounts receivable to current liabilities, excluding inventory, allowing investors to assess the company's ability to settle debts without selling inventory by analyzing the trend on this chart.

Main competitors